3.8 Article

Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing

期刊

CROHNS & COLITIS 360
卷 1, 期 3, 页码 -

出版社

OXFORD UNIV PRESS
DOI: 10.1093/crocol/otz033

关键词

healed pseudopolyps; inflammatory bowel disease; inflammatory pseudopolyps

资金

  1. Takeda
  2. National Institute of Health (NIH) [K23KD117054]
  3. Eli Lilly Pharmaceuticals
  4. Pfizer
  5. Prometheus

向作者/读者索取更多资源

Introduction: In this study, we identify the frequency of pseudopolyps (PPs) with normal histology and their association to surrounding tissue. Methods: Patients were enrolled in a study identifying endoscopic characteristics of PPs (n = 29) or were collected as part of our IBD biobank (n = 16). Statistical analysis included Stata v.15.0. chi-square and Student t-test. Results: A total of 45 patients with 117 PP biopsies were identified. More patients with healed PP were in endoscopic remission compared with those with inflammatory PP (82.6% vs 17.4%, respectively). Conclusion: This is the first study to find mucosal healing of PPs and its association with deep remission.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据